The company knows how important these trials are. They are essentially make it break for them and I think that's why we haven't seen ATHX make as many large moves as other stem cell companies who seem to continuously put out pr's and news. I think ATHX knows that to make everything perfect it's going to take time. That's why we've seen delays in data and why ATHX isn't as hyped a company as, say, CUR. But investors and followers who have done dd and know what the future holds are in a good position. Grab the shares while they are cheap. It's all right in our faces that the data is going to be good.
News 
Market Data 
Discover 
